OpenBind unveils its first AI model for drug discovery
A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Newsletters and Deep Dive digital magazine
A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
The companies that will lead in this next phase are those that treat AI as an integrated part of their operational architecture.
Automation shouldn’t mean the end of human contact, but the strategy needs to be human-first, technology-enabled.
Anthropic and the Gates Foundation's initiative will close a gap in access to AI tools between high- and lower-income countries.
As AI becomes more embedded within national health system priorities, the need for clear and responsible guardrails has become increasingly critical.
Editor's Picks
Newsletters and Deep Dive
digital magazine